Folic Acid and Its Receptors Jacqueline Spreadbury Governors State University
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Anti-FOLR2 Purified Cat
EXBIO Praha, a.s. • Nad Safinou II 341 • 252 50 Vestec • Czech Republic [email protected] • [email protected] • [email protected] • www.exbio.cz Technical Data Sheet Product Anti-FOLR2 Purified Cat. Number/Size 11-696-C025 0.025 mg 11-696-C100 0.1 mg For Research Use Only. Not for use in diagnostic or therapeutic procedures. Antigen FOLR2 Clone EM-35 Format Purified Reactivity Human Negative species Mouse Application FC (QC tested), IP, WB, ICC Application details Western blotting: Non-reducing conditions. Flow cytometry: Recommended dilution: 1-4 µg/ml Isotype Mouse IgG1 Specificity The mouse monoclonal antibody EM-35 recognizes an extracellular epitope on FOLR2, a 30-40 kDa cell surface protein serving as a receptor for folic acid. Other names Folate receptor beta, FBP, FR-P3, FR-BETA, BETA-HFR, FBP/PL-1 Immunogen BW5147alpha,beta- cells Entrez Gene ID 2350 Gene name FOLR2 NCBI Full Gene Name folate receptor beta UniProt ID P14207 Concentration 1 mg/ml Preparation Purified by protein-A affinity chromatography Formulation Phosphate buffered saline (PBS) solution with 15 mM sodium azide Storage and handling Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on the label. Images and References www.exbio.cz The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. -
Anti-FOLR2 Antibody (ARG41860)
Product datasheet [email protected] ARG41860 Package: 100 μl anti-FOLR2 antibody Store at: -20°C Summary Product Description Mouse Monoclonal antibody recognizes FOLR2 Tested Reactivity Hu Tested Application WB Host Mouse Clonality Monoclonal Clone 1905CT501.41.76 Isotype IgG2b, kappa Target Name FOLR2 Antigen Species Human Immunogen Recombiant protein of Human FOLR2. Conjugation Un-conjugated Alternate Names Folate receptor 2; BETA-HFR; FBP; Folate receptor beta; Folate receptor, fetal/placental; FBP/PL-1; FR- beta; FR-P3; Placental folate-binding protein; FR-BETA Application Instructions Application table Application Dilution WB 1:1000 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Human placenta Calculated Mw 29 kDa Observed Size ~ 33 kDa Properties Form Liquid Purification Purification with Protein G. Buffer PBS and 0.09% (W/V) Sodium azide. Preservative 0.09% (W/V) Sodium azide Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/2 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol FOLR2 Gene Full Name folate receptor 2 (fetal) Background The protein encoded by this gene is a member of the folate receptor (FOLR) family, and these genes exist in a cluster on chromosome 11. -
Status of Dhps and Dhfr Genes of Plasmodium Falciparum in Colombia Before Artemisinin Based Treatment Policy
Status of dhps and dhfr genes of Plasmodium falciparum in Colombia before artemisinin based treatment policy ARTÍCULO ORIGINAL Status of dhps and dhfr genes of Plasmodium falciparum in Colombia before artemisinin based treatment policy Estado de los genes dhps y dhfr de Plasmodium falciparum en Colombia antes de la recomendación de tratamiento basado en artemisinina Andrés Villa1†, Jaime Carmona-Fonseca1, Agustín Benito2, Alonso Martínez3, Amanda Maestre1 Abstract Introduction: Surveillance of the genetic characteristics of dhps and dhfr can be useful to outline guidelines for application of intermittent preven- tive therapy in Northwest Colombia and to define the future use of antifolates in artemisinin-based combination therapy schemes. Objective: To evaluate the frequency of mutations in dhps and dhfr and to characterize parasite populations using msp-1, msp-2 and glurp in historic samples before artemisinin-based therapy was implemented in the country. Methods: A controlled clinical study was carried out on randomly selected Plasmodium falciparum infected volunteers of Northwest Colombia (Turbo and Zaragoza). A sample size of 25 subjects per region was calculated. Treatment efficacy to antifolates was assessed. Molecular analyses included P. falcipa- rum genotypes by msp-1, msp-2 and glurp and evaluation of the status of codons 16, 51, 59, 108 and 164 of dhfr and 436, 437, 540, 581 and 613 of dhps. Results: In total 78 subjects were recruited. A maximum number of 4 genotypes were detected by msp-1, msp-2 and glurp. Codons 16, 59 and 164 of the dhfr gene exhibited the wild-type form, while codons 51 and 108 were mutant. -
Snps Detection in DHPS-WDR83 Overlapping Genes Mapping On
Zambonelli et al. BMC Genetics 2013, 14:99 http://www.biomedcentral.com/1471-2156/14/99 RESEARCH ARTICLE Open Access SNPs detection in DHPS-WDR83 overlapping genes mapping on porcine chromosome 2 in a QTL region for meat pH Paolo Zambonelli1*, Roberta Davoli1, Mila Bigi1, Silvia Braglia1, Luigi Francesco De Paolis1, Luca Buttazzoni2,3, Maurizio Gallo3 and Vincenzo Russo1 Abstract Background: The pH is an important parameter influencing technological quality of pig meat, a trait affected by environmental and genetic factors. Several quantitative trait loci associated to meat pH are described on PigQTL database but only two genes influencing this parameter have been so far detected: Ryanodine receptor 1 and Protein kinase, AMP-activated, gamma 3 non-catalytic subunit. To search for genes influencing meat pH we analyzed genomic regions with quantitative effect on this trait in order to detect SNPs to use for an association study. Results: The expressed sequences mapping on porcine chromosomes 1, 2, 3 in regions associated to pork pH were searched in silico to find SNPs. 356 out of 617 detected SNPs were used to genotype Italian Large White pigs and to perform an association analysis with meat pH values recorded in semimembranosus muscle at about 1 hour (pH1) and 24 hours (pHu) post mortem. The results of the analysis showed that 5 markers mapping on chromosomes 1 or 3 were associated with pH1 and 10 markers mapping on chromosomes 1 or 2 were associated with pHu. After False Discovery Rate correction only one SNP mapping on chromosome 2 was confirmed to be associated to pHu. -
Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development
G C A T T A C G G C A T genes Article Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development Jeremy W. Prokop 1,2,3,*, Caleb P. Bupp 1,4 , Austin Frisch 1, Stephanie M. Bilinovich 1 , Daniel B. Campbell 1,3,5, Daniel Vogt 1,3,5, Chad R. Schultz 1, Katie L. Uhl 1, Elizabeth VanSickle 4, Surender Rajasekaran 1,6,7 and André S. Bachmann 1,* 1 Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI 49503, USA; [email protected] (C.P.B.); [email protected] (A.F.); [email protected] (S.M.B.); [email protected] (D.B.C.); [email protected] (D.V.); [email protected] (C.R.S.); [email protected] (K.L.U.); [email protected] (S.R.) 2 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA 3 Center for Research in Autism, Intellectual, and Other Neurodevelopmental Disabilities, Michigan State University, East Lansing, MI 48824, USA 4 Spectrum Health Medical Genetics, Grand Rapids, MI 49503, USA; [email protected] 5 Neuroscience Program, Michigan State University, East Lansing, MI 48824, USA 6 Pediatric Intensive Care Unit, Helen DeVos Children’s Hospital, Grand Rapids, MI 49503, USA 7 Office of Research, Spectrum Health, Grand Rapids, MI 49503, USA * Correspondence: [email protected] (J.W.P.); [email protected] (A.S.B.) Abstract: Ornithine decarboxylase 1 (ODC1 gene) has been linked through gain-of-function variants Citation: Prokop, J.W.; Bupp, C.P.; to a rare disease featuring developmental delay, alopecia, macrocephaly, and structural brain anoma- Frisch, A.; Bilinovich, S.M.; Campbell, lies. -
Downloaded Per Proteome Cohort Via the Web- Site Links of Table 1, Also Providing Information on the Deposited Spectral Datasets
www.nature.com/scientificreports OPEN Assessment of a complete and classifed platelet proteome from genome‑wide transcripts of human platelets and megakaryocytes covering platelet functions Jingnan Huang1,2*, Frauke Swieringa1,2,9, Fiorella A. Solari2,9, Isabella Provenzale1, Luigi Grassi3, Ilaria De Simone1, Constance C. F. M. J. Baaten1,4, Rachel Cavill5, Albert Sickmann2,6,7,9, Mattia Frontini3,8,9 & Johan W. M. Heemskerk1,9* Novel platelet and megakaryocyte transcriptome analysis allows prediction of the full or theoretical proteome of a representative human platelet. Here, we integrated the established platelet proteomes from six cohorts of healthy subjects, encompassing 5.2 k proteins, with two novel genome‑wide transcriptomes (57.8 k mRNAs). For 14.8 k protein‑coding transcripts, we assigned the proteins to 21 UniProt‑based classes, based on their preferential intracellular localization and presumed function. This classifed transcriptome‑proteome profle of platelets revealed: (i) Absence of 37.2 k genome‑ wide transcripts. (ii) High quantitative similarity of platelet and megakaryocyte transcriptomes (R = 0.75) for 14.8 k protein‑coding genes, but not for 3.8 k RNA genes or 1.9 k pseudogenes (R = 0.43–0.54), suggesting redistribution of mRNAs upon platelet shedding from megakaryocytes. (iii) Copy numbers of 3.5 k proteins that were restricted in size by the corresponding transcript levels (iv) Near complete coverage of identifed proteins in the relevant transcriptome (log2fpkm > 0.20) except for plasma‑derived secretory proteins, pointing to adhesion and uptake of such proteins. (v) Underrepresentation in the identifed proteome of nuclear‑related, membrane and signaling proteins, as well proteins with low‑level transcripts. -
Extracellular Signal-Regulated Kinases Associate with and Phosphorylate
Wang et al. Oncogenesis (2020) 9:85 https://doi.org/10.1038/s41389-020-00271-1 Oncogenesis ARTICLE Open Access Extracellular signal-regulated kinases associate with and phosphorylate DHPS to promote cell proliferation Chao Wang1, Zhen Chen1, Litong Nie 1,MengfanTang1,XuFeng1,DanSu 1,HuiminZhang1,YunXiong1, Jeong-Min Park 1 and Junjie Chen 1 Abstract The ERK1/2 pathway is one of the most commonly dysregulated pathways in human cancers and controls many vital cellular processes. Although many ERK1/2 kinase substrates have been identified, the diversity of ERK1/2 mediated processes suggests the existence of additional targets. Here, we identified Deoxyhypusine synthase (DHPS), an essential hypusination enzyme regulating protein translation, as a major and direct-binding protein of ERK1/2. Further experiments showed that ERK1/2 phosphorylate DHPS at Ser-233 site. The Ser-233 phosphorylation of DHPS by ERK1/2 is important for its function in cell proliferation. Moreover, we found that higher DHPS expression correlated with poor prognosis in lung adenocarcinoma and increased resistance to inhibitors of the ERK1/2 pathway. In summary, our results suggest that ERK1/2-mediated DHPS phosphorylation is an important mechanism that underlies protein translation and that DHPS expression is a potent biomarker of response to therapies targeting ERK1/2-pathway. 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Introduction dependent signaling cascade and participate in the reg- The extracellular signal-regulated kinase 1/2 (ERK1/2) ulation of a variety of cellular processes2. Moreover, belongs to an essential signaling pathway that regulates abnormal regulation of ERK1/2 pathway has been repor- various stimuli-induced cellular processes, including cell ted in many different types of cancers, and drugs targeting – proliferation, differentiation, and survival1 4. -
Localization and Genomic Structure of Human Deoxyhypusine Synthase Gene on Chromosome 19P13.2-Distal 19P13.1
Gene 215 (1998) 153–157 Localization and genomic structure of human deoxyhypusine synthase gene on chromosome 19p13.2-distal 19p13.1 Elide Mantuano a,b, Flavia Trettel b, Anne S. Olsen c, Greg Lennon c, Marina Frontali a, Carla Jodice b,* a Istituto di Medicina Sperimentale, CNR, Rome, Italy b Dipartimento di Biologia, Universita` ‘Tor Vergata’, Via della Ricerca Scientifica-00133 Rome, Italy c Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, CA 94551, USA Received 2 February 1998; received in revised form 29 April 1998; accepted 29 April 1998; Received by E. Boncinelli Abstract The amino acid hypusine is formed post-translationally in a single cellular protein, the eukaryotic translation initiation factor 5A, by two enzymes, namely deoxyhypusine synthase and deoxyhypusine hydroxylase. Hypusine is found in all eukaryotes and in some archaebacteria, but not in eubacteria. The deoxyhypusine synthase cDNA was cloned and mapped by fluorescence in situ hybridization on chromosome 19p13.11-p13.12. Rare cDNAs containing internal deletions were also found. We localized the deoxyhypusine synthase gene on a high resolution cosmid/BAC contig map of chromosome 19 to a region in 19p13.2-distal 19p13.1 between MANB and JUNB. Analysis of the genomic exon/intron structure of the gene coding region showed that it consists of nine exons and spans a length of 6.6 kb. From observation of the genomic structure, it seems likely that the internally deleted forms of mature RNA are the result of alternative splicing, rather than of artifacts. © 1998 Elsevier Science B.V. All rights reserved. Keywords: Hypusine biosynthesis; DHPS gene isoforms; Cell proliferation 1. -
Computational Study of the Interactions Between Antimalarial Chemotherapies with Folate Pathway Receptors and Telomerase Reverse Transcriptase
Computational Chemistry, 2021, 9, 197-214 https://www.scirp.org/journal/cc ISSN Online: 2332-5984 ISSN Print: 2332-5968 Computational Study of the Interactions between Antimalarial Chemotherapies with Folate Pathway Receptors and Telomerase Reverse Transcriptase Djogang Lucie Karelle1,2, Forlemu Neville3, Emadak Alphonse1*, Njabon Njankwa Eric1, Issofa Patouossa1, Nenwa Justin2 1Physical and Theoretical Chemistry Laboratory, Faculty of Science, University of Yaounde I, Yaounde, Cameroon 2Applied Inorganic Chemistry Laboratory, Faculty of Science, University of Yaounde I, Yaounde, Cameroon 3School of Science & Technology (Chemistry), Georgia Gwinnett College, Lawrenceville, USA How to cite this paper: Karelle, D.L., Abstract Neville, F., Alphonse, E., Eric, N.N., Patou- ossa, I. and Justin, N. (2021) Computation- Malaria is a life-threatening disease responsible for half a million death an- al Study of the Interactions between Anti- nually, and with nearly half of the world’s population at risk. The rapid drop malarial Chemotherapies with Folate Path- in observed cases of malaria in the last two decades has been due to a combi- way Receptors and Telomerase Reverse Transcriptase. Computational Chemistry, 9, nation of preventive and therapeutic remedies. However, the absence of a 197-214. vaccine, new antimalarial chemotherapies and increased parasitic resistance https://doi.org/10.4236/cc.2021.93011 have led to a plateau of infections and renewed research interest in target human and Plasmodium (the malaria parasite) receptors and new drugs. In Received: May 13, 2021 this study, the impact of mutation on the affinity on antimalarial drugs with Accepted: July 23, 2021 Published: July 26, 2021 the bifunctional enzyme complex, dihydrofolate reductase (DHFR) is explored. -
Robust Sampling of Altered Pathways for Drug Repositioning Reveals
Fernández-Martínez JL, Álvarez O, De Andrés EJ, de la Viña JFS, Huergo L. Robust Sam- Journal of pling of Altered Pathways for Drug Repositioning Reveals Promising Novel Therapeutics for Rare Diseases Research Inclusion Body Myositis. J Rare Dis Res Treat. (2019) 4(2): 7-15 & Treatment www.rarediseasesjournal.com Research Article Open Access Robust Sampling of Altered Pathways for Drug Repositioning Reveals Promising Novel Therapeutics for Inclusion Body Myositis Juan Luis Fernández-Martínez*, Oscar Álvarez, Enrique J. DeAndrés-Galiana, Javier Fernández-Sánchez de la Viña, Leticia Huergo Group of Inverse Problems, Optimization and Machine Learning. Department of Mathematics. University of Oviedo, Oviedo, 33007, Asturias, Spain. Article Info ABSTRACT Article Notes In this paper we present a robust methodology to deal with phenotype Received: January 28, 2019 prediction problems associated to drug repositioning in rare diseases, which Accepted: April 3, 2019 is based on the robust sampling of altered pathways. We show the application *Correspondence: to the analysis of IBM (Inclusion Body Myositis) providing new insights about Dr. Juan Luis Fernández-Martínez, Group of Inverse the mechanisms involved in its development: cytotoxic CD8 T cell-mediated Problems, Optimization and Machine Learning. Department immune response and pathogenic protein accumulation in myofibrils related of Mathematics. University of Oviedo, Oviedo, 33007, to the proteasome inhibition. The originality of this methodology consists of Asturias, Spain; Email: [email protected]. performing a robust and deep sampling of the altered pathways and relating © 2019 Fernández-Martínez JL. This article is distributed under these results to possible compounds via the connectivity map paradigm. the terms of the Creative Commons Attribution 4.0 International The methodology is particularly well-suited for the case of rare diseases License. -
Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons. -
Transcriptional Profile of Human Anti-Inflamatory Macrophages Under Homeostatic, Activating and Pathological Conditions
UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD DE CIENCIAS QUÍMICAS Departamento de Bioquímica y Biología Molecular I TESIS DOCTORAL Transcriptional profile of human anti-inflamatory macrophages under homeostatic, activating and pathological conditions Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas MEMORIA PARA OPTAR AL GRADO DE DOCTOR PRESENTADA POR Víctor Delgado Cuevas Directores María Marta Escribese Alonso Ángel Luís Corbí López Madrid, 2017 © Víctor Delgado Cuevas, 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Víctor Delgado Cuevas Tesis Doctoral Madrid 2016 Universidad Complutense de Madrid Facultad de Ciencias Químicas Dpto. de Bioquímica y Biología Molecular I TRANSCRIPTIONAL PROFILE OF HUMAN ANTI-INFLAMMATORY MACROPHAGES UNDER HOMEOSTATIC, ACTIVATING AND PATHOLOGICAL CONDITIONS Perfil transcripcional de macrófagos antiinflamatorios humanos en condiciones de homeostasis, activación y patológicas. Este trabajo ha sido realizado por Víctor Delgado Cuevas para optar al grado de Doctor en el Centro de Investigaciones Biológicas de Madrid (CSIC), bajo la dirección de la Dra. María Marta Escribese Alonso y el Dr. Ángel Luís Corbí López Fdo. Dra. María Marta Escribese